These data suggest that, in the case of Wistar NPC stimulation with neurotrophins, the activation of PKA is induced, which, in turn, phosphorylates multiple intracellular substrates including GSK3β and results in the expected glutamatergic differentiation. The gene discussed is GSK3B; the disease is nasopharyngeal carcinoma.